Associated Papers
Understanding PI3K/Akt/mTOR signaling in squamous cell carcinoma: mutated PIK3CA as an example.
Zheng S et al.
Molecular Biomedicine, 2024
Mutations in TP53 and PIK3CA genes in hepatocellular carcinoma patients are associated with chronic Schistosomiasis.
AlGabbani Q
Saudi Journal of Biological Sciences, 2022
PIK3CA mutations frequently coexist with EGFR/KRAS mutations in non-small cell lung cancer and suggest poor prognosis in EGFR/KRAS wildtype subgroup.
Wang L et al.
Plos One, 2014
Analysing the mutational status of PIK3CA in circulating tumor cells from metastatic breast cancer patients.
Schneck H et al.
Molecular Oncology, 2013
The determinants of head and neck cancer: Unmasking the PI3K pathway mutations.
Giudice FS et al.
Journal of Carcinogenesis & Mutagenesis, 2013
Phosphatidylinositol-3-kinase and AKT1 mutations occur early in breast carcinoma.
Dunlap J et al.
Breast Cancer Research and Treatment, 2010
PIK3CA mutations are an early genetic alteration associated with FGFR3 mutations in superficial papillary bladder tumors.
López-Knowles E et al.
Cancer Research, 2006
Select a paper to view details